Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
17.8M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$120M
-
Value change
-
+$8.19M
-
Number of buys
-
28
-
Number of sells
-
-24
-
Price
-
$6.77
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2019
71 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q3 2019.
Apyx Medical Corp - Common Stock (APYX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.8M shares
of 35M outstanding shares and own 50.79% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.37M shares), Archon Capital Management LLC (2.74M shares), BlackRock Inc. (2.2M shares), VANGUARD GROUP INC (1.42M shares), RENAISSANCE TECHNOLOGIES LLC (653K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (652K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), STATE STREET CORP (558K shares), NORTHERN TRUST CORP (510K shares), and ROYCE & ASSOCIATES LP (466K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.